These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34046753)

  • 1. Material decomposition using iodine quantification on spectral CT for characterising nodules in the cirrhotic liver: a retrospective study.
    Laroia ST; Yadav K; Kumar S; Rastogi A; Kumar G; Sarin SK
    Eur Radiol Exp; 2021 May; 5(1):22. PubMed ID: 34046753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
    Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
    Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of small hepatic hemangioma from small hepatocellular carcinoma: recently introduced spectral CT method.
    Lv P; Lin XZ; Li J; Li W; Chen K
    Radiology; 2011 Jun; 259(3):720-9. PubMed ID: 21357524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
    Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
    Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease.
    Li JP; Zhao DL; Jiang HJ; Huang YH; Li DQ; Wan Y; Liu XD; Wang JE
    Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):43-9. PubMed ID: 21269934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine material density images in dual-energy CT: quantification of contrast uptake and washout in HCC.
    Pfeiffer D; Parakh A; Patino M; Kambadakone A; Rummeny EJ; Sahani DV
    Abdom Radiol (NY); 2018 Dec; 43(12):3317-3323. PubMed ID: 29774382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of quantitative iodine-based material decomposition images with gemstone spectral CT imaging in the follow-up of patients with hepatocellular carcinoma after TACE treatment].
    Xing G; Wang S; Li C; Zhao X; Zhou C
    Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):208-12. PubMed ID: 25975791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT.
    Kaltenbach B; Wichmann JL; Pfeifer S; Albrecht MH; Booz C; Lenga L; Hammerstingl R; D'Angelo T; Vogl TJ; Martin SS
    Eur J Radiol; 2018 Aug; 105():20-24. PubMed ID: 30017280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
    Duan Y; Xie X; Li Q; Mercaldo N; Samir AE; Kuang M; Lin M
    Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
    Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
    Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of contrast-enhanced intraoperative ultrasound for cirrhotic patients with hepatocellular carcinoma: a report of 20 cases.
    Lu Q; Luo Y; Yuan CX; Zeng Y; Wu H; Lei Z; Zhong Y; Fan YT; Wang HH; Luo Y
    World J Gastroenterol; 2008 Jul; 14(25):4005-10. PubMed ID: 18609684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of dysplastic nodule diagnosis in patients with liver cirrhosis on unenhanced and gadobenate dimeglumine-enhanced MRI with dynamic and hepatobiliary phase.
    Quaia E; De Paoli L; Pizzolato R; Angileri R; Pantano E; Degrassi F; Ukmar M; Cova MA
    AJR Am J Roentgenol; 2013 Mar; 200(3):553-62. PubMed ID: 23436844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients.
    Galia M; Agnello F; Sparacia G; Matranga D; Albano D; Midiri M; Lagalla R
    Radiol Med; 2018 Jul; 123(7):489-497. PubMed ID: 29546493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
    Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
    Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
    Fischer MA; Marquez HP; Gordic S; Leidner B; Klotz E; Aspelin P; Alkadhi H; Brismar TB
    Eur Radiol; 2017 Mar; 27(3):1074-1080. PubMed ID: 27368924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre-liver transplant patients: radiologic-histopathologic correlation of explanted livers.
    Freeny PC; Grossholz M; Kaakaji K; Schmiedl UP
    Abdom Imaging; 2003; 28(3):333-46. PubMed ID: 12719903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound-detected liver nodules.
    Franzè MS; Bottari A; Caloggero S; Pitrone A; Barbera A; Lembo T; Caccamo G; Cacciola I; Maimone S; Alibrandi A; Pitrone C; Squadrito G; Raimondo G; Saitta C
    Intern Emerg Med; 2021 Jun; 16(4):949-955. PubMed ID: 33111165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.